Cordlife Group Executive and Leadership Team

Yiu Pang Fai, the Group Chief Executive Officer at Cordlife Group, directs the overarching corporate strategy and long-term vision for the organization. This leadership role involves managing the expansion of diagnostic service portfolios, specifically focusing on non-invasive prenatal testing and pediatric vision screening. By aligning internal resources with market demands, the Group Chief Executive Officer ensures the company maintains a competitive edge in the health services sector. Yiu Pang Fai monitors financial performance and investor relations to secure sustainable growth across international territories. Through rigorous oversight of corporate governance, the Group Chief Executive Officer maintains high standards of clinical excellence. This executive position requires constant evaluation of emerging medical technologies to enhance the diagnostic suite. Ultimately, the Group Chief Executive Officer drives the mission of providing accessible, high-quality genetic screening solutions to families worldwide, ensuring the company remains a leader in the diagnostic industry.

Shally Chen, the Executive Director and Singapore Chief Executive Officer at Cordlife Group, manages the primary diagnostic operations and clinical service delivery within the domestic market. This role involves supervising the implementation of urine-based newborn metabolic screening protocols and ensuring strict adherence to regional health regulations. Shally Chen coordinates with the board to refine operational workflows, directly impacting the efficiency of family genetic screening services. By optimizing local laboratory processes, the Executive Director and Singapore Chief Executive Officer improves turnaround times for critical diagnostic results. This leadership function requires close collaboration with medical professionals to maintain service quality and patient trust. Through strategic resource allocation, the Executive Director and Singapore Chief Executive Officer strengthens the market position of the company within the region. This executive role remains vital for scaling diagnostic capabilities and ensuring that all clinical offerings meet the highest standards of accuracy and reliability for families.

Poh Tan, the Group Chief Executive Officer at Cordlife Group, architects the global business development framework and strategic partnerships necessary for market penetration. This leadership role focuses on identifying new opportunities for pediatric vision screening and expanding the reach of diagnostic services into emerging markets. Poh Tan oversees the integration of advanced genetic screening technologies into the existing service ecosystem, ensuring the company remains at the forefront of medical innovation. By fostering relationships with healthcare providers and institutional stakeholders, the Group Chief Executive Officer drives revenue growth and brand recognition. This executive position involves analyzing complex market data to guide investment decisions and operational scaling. Through proactive management of cross-functional teams, the Group Chief Executive Officer ensures that all diagnostic initiatives align with the core mission of improving family health outcomes. This leadership role ultimately secures the long-term viability and market influence of the organization on a global scale.

Sally Goh, the Group Chief Operating Officer at Cordlife Group, manages the daily execution of diagnostic service workflows and internal infrastructure. This role involves streamlining the logistics of urine-based metabolic screening and ensuring the seamless operation of laboratory facilities. Sally Goh directs the implementation of quality control measures across all diagnostic departments to maintain operational excellence. By optimizing supply chain processes and resource management, the Group Chief Operating Officer enhances the overall efficiency of service delivery. This leadership function requires constant monitoring of operational metrics to identify areas for improvement and cost reduction. Through the coordination of technical teams, the Group Chief Operating Officer ensures that all diagnostic services meet rigorous safety and accuracy standards. This executive position supports the broader corporate strategy by providing a stable and scalable operational foundation. Ultimately, the Group Chief Operating Officer drives the internal performance necessary to deliver reliable health services to families.